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Mean changes and 95% CI's were determined from linear regression models with 3-month and 6-month change in periodontal outcomes included as dependent variables, treatment group as an independent factor and the Clinical Site as a covariate; p-values were based on t-tests comparing mean changes between the two groups.
c Each periodontal measurement was evaluated on 6 sites of each tooth. A participant-based summary measurement was determined by first calculating an average of the six sites per tooth and then calculating an average for all teeth measured for that participant.
d P values were > 0.05 after adjustment for multiple comparisons using Bonferroni's correction.
e Bleeding on Probing data not obtained (n=1 at the 3-month visit in the Treatment Group; n=1 at the 6-month visit in the Control Group). (-4.2, 0.9) (-4.6, 0.6) (-5.4, 0.0) (-7.7, -2.2) (-12.1, 24.8) (3.9, 40.9) (-8.9, 25.6) (-4.5, 29.4 (-2.4, 15. 3) (-3.9, 14 .1) (-12.7, 7.4) (-12.5, 8. (-19.9, 17. 3) (-23.4, 14.6 ) (-44.2, 0.79 ) (-38.1, 8.1) a Per protocol: Analyses were based on all participants with HbA 1c data at the 6-month visit (n=240 in the Treatment group, n=235 in the Control Group). Differences in sample sizes reflect missing data due to missed visits or inability to collect or processs data at the 3 or 6 month visit.
b Mean changes and 95% CI's were determined from linear regression models with 3-month and 6-month change in outcome included as dependent variables, treatment group as an independent factor and the Clinical Site as a covariate; p-values were based on t-tests comparing mean changes between the two groups.
c Excluded participants reporting insulin use.
d
HOMA2 was calculated using the HOMA2 calculator version 2.2 (http://www.dtu.ox.ac.uk/homacalculator/index.php).
